Trial intelligence / Profile preview

Ropivacaine TAP block versus rectus sheath block for postoperative pain after laparoscopic cholecystectomy

IRCT20190511043550N5Phase 2Completed

Sponsor
Shiraz University of Medical Sciences
Start
May 2024
Modality
Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
Countries
1
01

Overview

Phase 2, randomised, double-blind trial of ropivacaine in postoperative pain (2 arms), sponsored by Shiraz University of Medical Sciences. Primary endpoint: Pain. Started May 2024; status: completed.

02

Drugs

ropivacaine
03

Conditions

postoperative pain

Beyond the preview

Go deeper on IRCT20190511043550N5.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on IRCT20190511043550N5.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call